Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence

.

Source: Human Vaccines and Immunotherapeutics - June 11, 2020 Category: Allergy & Immunology Authors: Erica Chilson Daniel A. Scott Beate Schmoele-Thoma Wendy Watson Mary M. Moran Raul Isturiz Source Type: research